Unlocking the Potential: Mineralys Therapeutics to Showcase Groundbreaking Research at Two November Conferences
Mineralys Therapeutics, Inc. (Nasdaq: MLYS) recently made a significant announcement regarding their upcoming poster presentations at two prestigious events in 2023 – ASN’s Kidney Week and AHA’s Scientific Sessions. The company, known for its focus on developing medicines to target hypertension and chronic kidney disease driven by abnormally elevated aldosterone, is set to present groundbreaking…